ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $563 | $473 | $234 | $558 |
| - Cash | $59 | $23 | $67 | $226 |
| + Debt | $9 | $10 | $3 | $2 |
| Enterprise Value | $513 | $460 | $169 | $334 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$127 | -$110 | -$86 | -$78 |
| % Margin | – | – | – | – |
| Net Income | -$128 | -$101 | -$89 | -$79 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.83 | -1.96 | -2.25 | -2.07 |
| % Growth | 6.6% | 12.9% | -8.7% | – |
| Operating Cash Flow | -$113 | -$86 | -$75 | -$60 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$114 | -$87 | -$77 | -$60 |